REGULATION OF HUMORAL IMMUNE-RESPONSES TO HLA BY ANTI-IDIOTYPIC ANTIBODIES

被引:0
|
作者
REED, E [1 ]
MCMANUS, P [1 ]
HERNADI, S [1 ]
SUCIUFOCA, N [1 ]
机构
[1] COLUMBIA UNIV,DEPT PATHOL,NEW YORK,NY 10027
关键词
D O I
10.1016/0198-8859(88)90238-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:137 / 137
页数:1
相关论文
共 50 条
  • [31] Idiotypes and anti-idiotypic antibodies: A review
    Ameri M.
    Zhou E.-M.
    Comparative Clinical Pathology, 2006, 14 (4) : 171 - 178
  • [32] SPECIFIC DETECTION OF ANTI-IDIOTYPIC IMMUNE-RESPONSES IN CANCER-PATIENTS TREATED WITH MURINE MONOCLONAL-ANTIBODY
    HERLYN, D
    LUBECK, M
    SEARS, H
    KOPROWSKI, H
    JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 85 (01) : 27 - 38
  • [33] DYNAMICS OF THE FORMATION OF ANTI-IDIOTYPIC ANTIBODIES IN THE COURSE OF IMMUNE-RESPONSE
    KOSITSKAYA, LS
    SOFRONOV, BN
    ZHURNAL MIKROBIOLOGII EPIDEMIOLOGII I IMMUNOBIOLOGII, 1984, (04): : 83 - 86
  • [34] ANTI-IDIOTYPIC ANTIBODIES TO HLA-DR4 AND DR2
    REED, E
    BONAGURA, V
    KUNG, P
    KING, DW
    SUCIUFOCA, N
    JOURNAL OF IMMUNOLOGY, 1983, 131 (06): : 2890 - 2894
  • [35] Anti-idiotypic antibodies: From regulation to therapy of factor VIII inhibitors
    Saint-Remy, JMR
    Jacquemin, MG
    Gilles, JG
    VOX SANGUINIS, 1999, 77 : 21 - 24
  • [36] REGULATION OF IMMUNE-RESPONSES VIA GENETICALLY RESTRICTED CELLULAR INTERACTIONS .2. I-REGION-RESTRICTED COOPERATION BETWEEN IDIOTYPIC AND ANTI-IDIOTYPIC LYMPHOCYTES-B
    YAMAMOTO, H
    BITOH, S
    FUJIMOTO, S
    CELLULAR IMMUNOLOGY, 1985, 94 (02) : 579 - 586
  • [37] ANTI-IDIOTYPIC REGULATION OF ALLOANTIGEN RESPONSIVENESS
    GORCZYNSKI, RM
    MACRAE, S
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 1078 - 1078
  • [38] ANALYSIS OF IDIOTYPIC AND ANTI-IDIOTYPIC ANTIBODIES AS MODELS OF RECEPTOR AND LIGAND
    LINTHICUM, DS
    BOLGER, MB
    KUSSIE, PH
    ALBRIGHT, GM
    LINTON, TA
    COMBS, S
    MARCHETTI, D
    CLINICAL CHEMISTRY, 1988, 34 (09) : 1676 - 1680
  • [39] Humoral anti-idiotypic and anti-anti-idiotypic immune response in cancer patients treated with monoclonal antibody 17-1A
    Fagerberg, J
    Ragnhammar, P
    Liljefors, M
    Hjelm, AL
    Mellstedt, H
    Frodin, JE
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 1996, 42 (02) : 81 - 87
  • [40] IVIG has anti-complement but not anti-idiotypic activity against HLA antibodies.
    Watanabe, J
    Scornik, J
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 245 - 245